Older Adults (65-85 Years) clinical trials at UCSF
1 research study open to eligible people
Older adults are people who are 65 to 85 years old. UCSF is examining whether healthy older adults have side effects after psilocybin dosing. The study records heart rate, blood pressure, and reported symptoms.
Showing trials for
Psilocybin in Healthy Older Adults
open to eligible people ages 65-85
This study plans to learn more about the safety and tolerability of psychedelic administration (psilocybin) in healthy older adults ages 65-85.
San Francisco, California and other locations
Our lead scientists for Older Adults (65-85 Years) research studies include Jennifer Mitchell, PhD.
Last updated: